Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT01563952
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT01563952
-
- Other papers using this trial's data
- Clinical Impact of Intravascular Ultrasound-Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation: Randomized Study
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01563952. Randomized; single masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2013-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents
- Acronym
- CTO
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Non-IVUS guided intervention with Endeavor Resolute stent (zotarolimus-eluting stent, Medtronic)
- Intervention (Device)
- IVUS guided intervention with Endeavor Resolute stent (zotarolimus-eluting stent, Medtronic)
- Intervention (Device)
- Non-IVUS guided intervention with Nobori stent (biolimus A9-eluting stent, Terumo)
- Intervention (Device)
- IVUS guided intervention with Nobori stent (biolimus A9-eluting stent, Terumo)
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct01563952- Content hash
c039207d669e46e257203258dd066e691e25e09c7661b1a57594ea8d3dd23de5